Pharmacokinetic aspects during continuous ambulatory peritoneal dialysis: a literature review.
Since its introduction some years ago continuous ambulatory peritoneal dialysis (CAPD) has proved to be a valuable alternative to haemodialysis in the treatment of uraemia. Factors contributing to the transport of solutes through the peritoneal membrane are discussed and the literature concerning the pharmacokinetic aspects of CAPD is reviewed.
D000617:Aminoglycosides / Q000378:metabolism; D000900:Anti-Bacterial Agents / Q000378:metabolism; D000935:Antifungal Agents / Q000378:metabolism; D002511:Cephalosporins / Q000378:metabolism; D002927:Cimetidine / Q000378:metabolism; D004338:Drug Combinations / Q000378:metabolism; D006207:Half-Life; D006801:Humans; D007700:Kinetics; D010406:Penicillins / Q000378:metabolism; D010530:Peritoneal Dialysis; D010531:Peritoneal Dialysis, Continuous Ambulatory; D004364:Pharmaceutical Preparations / Q000378:metabolism*; D013420:Sulfamethoxazole / Q000378:metabolism; D014295:Trimethoprim / Q000378:metabolism; D015662:Trimethoprim, Sulfamethoxazole Drug Combination; D014640:Vancomycin / Q000378:metabolism
D000617:Aminoglycosides; D000900:Anti-Bacterial Agents; D000935:Antifungal Agents; D002511:Cephalosporins; D004338:Drug Combinations; D010406:Penicillins; D004364:Pharmaceutical Preparations; D014640:Vancomycin; D002927:Cimetidine; D015662:Trimethoprim, Sulfamethoxazole Drug Combination; D014295:Trimethoprim; D013420:Sulfamethoxazole